<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Clin Pract Epidemiol Ment Health</journal-id><journal-id journal-id-type="iso-abbrev">Clin Pract Epidemiol Ment Health</journal-id><journal-id journal-id-type="publisher-id">CPEMH</journal-id><journal-title-group><journal-title>Clinical Practice and Epidemiology in Mental Health : CP &#x00026; EMH</journal-title></journal-title-group><issn pub-type="epub">1745-0179</issn><publisher><publisher-name>Bentham Open</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29515644</article-id><article-id pub-id-type="pmc">5827302</article-id><article-id pub-id-type="publisher-id">CPEMH-14-11</article-id><article-id pub-id-type="doi">10.2174/1745017901814010011</article-id><article-categories><subj-group subj-group-type="heading"><subject>Clinical Practice &#x00026; Epidemiology in Mental Health</subject></subj-group></article-categories><title-group><article-title>Effects of Aerobic Exercise on Anxiety Symptoms and Cortical Activity in Patients with Panic Disorder: A Pilot Study</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Lattari</surname><given-names>Eduardo</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Budde</surname><given-names>Henning</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Paes</surname><given-names>Fl&#x000e1;via</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Neto</surname><given-names>Geraldo Albuquerque Maranh&#x000e3;o</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Appolinario</surname><given-names>Jos&#x000e9; Carlos</given-names></name><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Nardi</surname><given-names>Ant&#x000f4;nio Eg&#x000ed;dio</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Murillo-Rodriguez</surname><given-names>Eric</given-names></name><xref ref-type="aff" rid="aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Machado</surname><given-names>S&#x000e9;rgio</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib><aff id="aff1">
<label>1</label>Laboratory of Panic and Respiration, Institute of Psychiatry, Federal University of Rio de Janeiro (IPUB/UFRJ), Rio de Janeiro, Brazil</aff><aff id="aff2">
<label>2</label>Faculty of Human Sciences, Medical School Hamburg, Kaiserkai 1, 20457 Hamburg, Germany, Lithuanian Sports University, Kaunas, Lithuania, Physical Activity, Physical Education, Health and Sport Research Centre (PAPESH), Sports Science Department, School of Science and Engineering, Reykjavik University, Reykjavik, Iceland</aff><aff id="aff3">
<label>3</label>Physical Activity Sciences Post-Graduate Program (PGCAF), Salgado de Oliveira University, Niteroi, Brazil</aff><aff id="aff4">
<label>4</label>
Federal University of Rio de Janeiro (IPUB/UFRJ), Rio de Janeiro, Brazil</aff><aff id="aff5">
<label>5</label>Laboratorio de Neurociencias Moleculares e Integrativas. Escuela de Medicina, Division Ciencias de la Salud, Universidad Anahuac Mayab. Merida, Yucatan. Mexico</aff><aff id="aff6">
<label>6</label>Laboratory of Physical Activity Neuroscience, Physical Activity Sciences Post-Graduate Program (PGCAF), Salgado de Oliveira University, Niteroi, Brazil</aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>Address correspondence to this author at the Laboratory of Panic and Respiration (LABPR), Institute of Psychiatry of Federal University of Rio de Janeiro (IPUB/UFRJ), Rio de Janeiro, Brazil; Tel: +5521991567006; E-mails: <email xlink:href="secm80@gmail.com">secm80@gmail.com</email>; <email xlink:href="secm80@yahoo.com.br">secm80@yahoo.com.br</email></corresp></author-notes><pub-date pub-type="epub"><day>21</day><month>2</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>14</volume><fpage>11</fpage><lpage>25</lpage><history><date date-type="received"><day>4</day><month>7</month><year>2017</year></date><date date-type="rev-recd"><day>28</day><month>11</month><year>2017</year></date><date date-type="accepted"><day>1</day><month>12</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9; 2018 Lattari <italic>et al</italic>.</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Bentham Open.</copyright-holder><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/legalcode"><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: <uri xlink:type="simple" xlink:href="https://creativecommons.org/licenses/by/4.0/legalcode">https://creativecommons.org/licenses/by/4.0/legalcode</uri>. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><abstract><sec><title>Background:</title><p>The effects of the aerobic exercise on anxiety symptoms in patients with Panic Disorder (PD) remain unclear. Thus, the investigation of possible changes in EEG frontal asymmetry could contribute to understand the relationship among exercise, brain and anxiety.</p></sec><sec><title>Objective:</title><p>To investigate the acute effects of aerobic exercise on the symptoms of anxiety and the chronic effects of aerobic exercise on severity and symptoms related to PD, besides the changes in EEG frontal asymmetry.</p></sec><sec><title>Methods:</title><p>Ten PD patients were divided into two groups, Exercise Group (EG; n=5) and Control Group (CG; n=5), in a randomized allocation. At baseline and post-intervention, they submitted the psychological evaluation through Panic Disorder Severity Scale (PDSS), Beck Anxiety Inventory (BAI), Beck Depression Inventory-II (BDI-II), EEG frontal asymmetry, and maximal oxygen consumption (VO<sub>2</sub>max). On the second visit, the patients of EG being submitted to the aerobic exercise (treadmill, 25 minutes, and 50-55% of heart rate reserve) and the CG remained seated for the same period of time. Both groups submitted a psychological evaluation with Subjective Units of Distress Scale (SUDS) at baseline, immediately after (Post-0), and after 10 minutes of the rest pause (Post-10). The patients performed 12 sessions of aerobic exercise with 48-72 hours of interval between sessions.</p></sec><sec><title>Results:</title><p>In EG, SUDS increased immediately after exercise practice and showed chronic decrease in BAI and BDI-II as well as increased in VO<sub>2</sub>max (Post-intervention).</p></sec><sec><title>Conclusion:</title><p>Aerobic exercise can promote increase in anxiety acutely and regular aerobic exercise promotes reduction in anxiety levels.</p></sec></abstract><kwd-group kwd-group-type="author"><title>Keywords</title><kwd>Exercise</kwd><kwd>Aerobic exercise</kwd><kwd>Anxiety</kwd><kwd>EEG frontal asymmetry</kwd><kwd>Anxiety Disorders</kwd><kwd>Panic Disorder</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><label>1</label><title>INTRODUCTION</title><p>Panic Disorder (PD) can be characterized by recurrent and unexpected Panic Attacks (PAs) where at least one of the attacks was followed by a persistent concern about new attacks and their consequences for a period of one month or more [<xref rid="r1" ref-type="bibr">1</xref>]. Lifetime prevalence of PD is 1.7% with a median age of onset by 32 years and 80.4% of persons with lifetime PD had a comorbid mental disorder [<xref rid="r2" ref-type="bibr">2</xref>]. Besides PD associations with mental disorders, it is also associated with clinical comorbidities [<xref rid="r3" ref-type="bibr">3</xref>], loss of productivity, well-being, social contact and self-realization [<xref rid="r4" ref-type="bibr">4</xref>], causing considerable health costs [<xref rid="r5" ref-type="bibr">5</xref>].</p><p>First-line treatments for PD are selective serotonin reuptake inhibitors, serotonin-noradrenaline reuptake inhibitors, calcium channel modulator pregabalin, tricyclic antidepressants [<xref rid="r6" ref-type="bibr">6</xref>], and benzodiazepines [<xref rid="r7" ref-type="bibr">7</xref>]. However, long-term tolerability issues associated with antidepressants and benzodiazepines exposure should also be carefully considered [<xref rid="r8" ref-type="bibr">8</xref>]. In addition, 20% of PD patients are refractory to standard treatments [<xref rid="r9" ref-type="bibr">9</xref>]. Within this context, potential treatment options for PD patients, such as Cognitive Behavioural Therapy (CBT) and other variants of behavior therapy [<xref rid="r6" ref-type="bibr">6</xref>], as well physical exercise [<xref rid="r10" ref-type="bibr">10</xref>] have attracted attention in the literature.</p><p>With respect to physical exercise, more specifically aerobic exercise, studies has been used it in PD patients demonstrating acute anxiolytic and antipanic effects [<xref rid="r11" ref-type="bibr">11</xref>, <xref rid="r12" ref-type="bibr">12</xref>]. Esquivel <italic>et al.</italic> [<xref rid="r11" ref-type="bibr">11</xref>] compared two conditions of aerobic exercise, high intensity versus low intensity, on the antipanic effects after inhaling 35% of carbon dioxide (CO<sub>2</sub>). PA reactions to CO<sub>2</sub> were lower in patients who underwent high intensity aerobic exercise compared to low intensity. Results also demonstrated the capacity of aerobic exercise to minimize anxiety symptoms in PD patients after use of substances that induce a PAs, such as caffeine [<xref rid="r13" ref-type="bibr">13</xref>], cholecystokinin-tetrapeptide (CCK-4) [<xref rid="r14" ref-type="bibr">14</xref>], and CO<sub>2</sub> [<xref rid="r11" ref-type="bibr">11</xref>]. However, other studies showed that aerobic exercise induces an increase in anxiety in PD patients [<xref rid="r14" ref-type="bibr">14</xref>, <xref rid="r15" ref-type="bibr">15</xref>]. Rief and Hermanutz [<xref rid="r15" ref-type="bibr">15</xref>] found that aerobic exercise, during two minutes and intensity of 75 watts, was sufficient to lead to increase in anxiety in PD patients. Strohle <italic>et al.</italic> [<xref rid="r14" ref-type="bibr">14</xref>] also demonstrated that 30 minutes of aerobic exercise, with an intensity of 70% of maximal oxygen consumption (VO<sub>2</sub>max), generated increase in anxiety. This alteration was observed in somatic symptoms [<xref rid="r14" ref-type="bibr">14</xref>], suggesting that patients with PD are more vulnerable to experiencing somatic symptoms after aerobic exercise [<xref rid="r15" ref-type="bibr">15</xref>]. However, Martinsen <italic>et al.</italic> [<xref rid="r16" ref-type="bibr">16</xref>] showed that twenty-four hospitalized PD patients completed supramaximal exercise tests (3-minute steady-state exercise test and workload at 110%) and all experienced high values of lactate (10.7 mmol/L), but only 1 patient experienced a PA during the exercise testing. Thus, the acute effect generated by aerobic exercise on anxiety symptoms in PD patients remains unclear.</p><p>Another question persists if aerobic exercise promotes, in the long term, anxiolytic effect in PD patients [<xref rid="r17" ref-type="bibr">17</xref>]. Meyer <italic>et al.</italic> [<xref rid="r17" ref-type="bibr">17</xref>] submitted patients to three experimental groups, clomipramine, aerobic exercise or placebo. They showed that treatment with clomipramine was more effective in disease severity and anxiety symptoms compared to aerobic exercise. Aerobic exercise was more effective in anxiety symptoms compared to placebo only at the end of the study (<italic>i.e.</italic>, week 10). Bandelow <italic>et al.</italic> [<xref rid="r18" ref-type="bibr">18</xref>] evaluated three treatment modalities: running, clomipramine or placebo. Treatment efficacy was measured with the Panic and Agoraphobia Scale (P &#x00026;A) and other rating scales. According to the P &#x00026;A and other scales, both exercise and clomipramine lead to significant decrease in symptoms compared to placebo treatment. Again clomipramine was significantly more effective and improved anxiety symptoms significantly earlier than exercise. In a study carried by Wedekind <italic>et al.</italic> [<xref rid="r19" ref-type="bibr">19</xref>] patients with PD were submitted to four experimental groups, aerobic exercise with paroxetine, relaxation with paroxetine, aerobic exercise with placebo, or relaxation with placebo. The results showed response and remission rates only in paroxetine group. No improvement was observed in aerobic exercise. Thus, the ability of aerobic exercise to promote long-term improvements in anxiety in PD patients is questionable.</p><p>Of particular interest to the present study are models that link frontal brain asymmetry to individual differences in affective style. This frontal asymmetry particularly postulated within the alpha frequency band (8-12 Hz) is the main base of Davidson model [<xref rid="r20" ref-type="bibr">20</xref>]. The model proposed by Davidson <italic>et al.</italic> demonstrates that left frontal areas of the brain mediating the experience of positive emotions and approach behaviors, and right frontal areas of the brain mediating the experience of negative emotions and withdrawal behaviors were associated with higher activation of the right frontal cortex and positive affective responses were associated with higher activation of the left frontal cortex [<xref rid="r20" ref-type="bibr">20</xref>]. These patterns of frontal Electroencephalographic (EEG) asymmetry may serve as an index of risk for a variety of emotion-related disorders. Patients with major depression [<xref rid="r21" ref-type="bibr">21</xref>] and social anxiety [<xref rid="r22" ref-type="bibr">22</xref>, <xref rid="r23" ref-type="bibr">23</xref>] have been shown significant relative elevations in right frontal brain activity when assessed during resting states or periods of acute emotional provocation, supporting these theoretical predictions [<xref rid="r24" ref-type="bibr">24</xref>].</p><p>According to our knowledge, there are no studies published that investigated changes in EEG frontal activity among individuals with PD before and after aerobic exercise. In health subjects, Petruzzelo and Tate showed that EEG frontal asymmetry was predictive of positive affect immediately after exercise using intensities close to the ventilatory threshold (70% of VO<sub>2</sub>max) [<xref rid="r25" ref-type="bibr">25</xref>]. However, EEG frontal asymmetry measured followed by aerobic exercise conditions, was influenced by three exercise intensities (45%, 60% and 75% VO<sub>2</sub>max), and associated with increase in the vigor imposed no differences between three intensities [<xref rid="r26" ref-type="bibr">26</xref>]. Although no studies to date have investigated patterns of change in EEG frontal activity among individuals with PD before and after aerobic exercise, Lattari <italic>et al.</italic> [<xref rid="r27" ref-type="bibr">27</xref>] demonstrated that aerobic exercise did not change the frontal asymmetry in health subjects.</p><p>Thus, the acute and chronic effects generated by aerobic exercise on anxiety symptoms in patients with PD remain inconclusive. In addition, the intensity of effort that promotes anxiolytic effects remains unanswered. Acutely, the intensity of aerobic exercise has been reported objectively [<xref rid="r11" ref-type="bibr">11</xref>, <xref rid="r14" ref-type="bibr">14</xref>, <xref rid="r15" ref-type="bibr">15</xref>], but it is not known until now whether it causes an increase or decrease in anxiety in patients with PD. Chronically, research used this variable in an arbitrary form [<xref rid="r19" ref-type="bibr">19</xref>, <xref rid="r28" ref-type="bibr">28</xref>], only one study that determined the intensity of effort in an objective form [<xref rid="r10" ref-type="bibr">10</xref>]. Details on the intensity, frequency and duration may further support the clinical administration of the exercise in patients with panic disorder [<xref rid="r29" ref-type="bibr">29</xref>]. Of particular interest to the present study is the investigation patterns of change in EEG frontal activity among individuals with PD before and after aerobic exercise and to evaluate predictions on levels of anxiety.</p><p>Besides, the study had the following objectives: 1) to investigate the acute effects of aerobic exercise on symptoms of anxiety; 2) to investigate the chronic effects of aerobic exercise on severity and symptoms related to PD, besides the changes on EEG frontal asymmetry. Our hypothesis for acute effects is that exercise compared to resting condition will provide further increases in anxiety immediately after, with significant reductions after 10 minutes of recovery. The regular practice of aerobic exercise will have greater reductions in severity and symptoms related to PD, as well as a increase in frontal asymmetry compared to control group.</p></sec><sec sec-type="methods"><label>2</label><title>METHODS</title><sec><label>2.1</label><title>Patients</title><p>The recruited patients had a diagnosis of PD according to Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR) (<italic>i.e.</italic>, unexpected PAs in the last month) [<xref rid="r1" ref-type="bibr">1</xref>] with at least 5 years of disease duration. The patients should be symptomatic by Panic Disorder Severity Scale (&#x0201c;PDSS&#x0201d;) (&#x0003e; 10 points, moderately ill). Diagnoses were made by an experienced psychologist using the Structured Clinical Interview for DSM-IV-TR. The exclusion criteria were: pregnancy, lactation, severe medical illness, organic brain damage, bipolar affective disorder, severe major depression, psychotic symptoms, alcohol or drug abuse, anorexia or bulimia nervosa, and regular aerobic exercise. The patients were sedentary and for participation in aerobic exercise, patients were requested to be authorizated by their cardiologist. Patients were not allowed to undergo additional psychological treatment during the study. Patients should be in continued treatment with any psychotropic drugs at least two weeks before baseline. The patients were in regular use with the selective serotonin reuptake inhibitors 150mg/day (fluoxetine, paroxetine, and citalopram) and/or benzodiazepines 3mg/day (clonazepam). Ten patients were eligible for the study in accordance with the inclusion and exclusion criteria. Each patient was clarified of all the experimental procedures and signed a written consent form, with the experiment was approved by the institutional ethics committee of the Federal University of Rio de Janeiro. The patients characterization can be observed in Table <bold><xref ref-type="table" rid="T1">1</xref></bold>.</p></sec><sec><label>2.2</label><title>Experimental Procedures</title><p>On the first visit (1<sup>st</sup> day) to the Panic and Respiration of Laboratory, the patients were submitted to a battery of psychological evaluation (diagnosis of PD with DSM-IV-TR, Panic Disorder Severity Scale, Beck Anxiety Inventory, and Beck Depression Inventory II), recording the electroencephalographic activity (resting EEG asymmetry), and determining the maximum oxygen consumption (VO<sub>2</sub>max) (Baseline). Ten patients were included and randomly assigned to two groups, Exercise group (n=5) and Control group (n=5).</p><p>On the second visit (2<sup>nd</sup>) to the laboratory, the patients of exercise group were submitted to the aerobic exercise protocol (see &#x0201c;Aerobic Exercise Protocol&#x0201d;). Patients in the control group remained seated comfortably in an armchair for the same period of time. Both groups were submitted a psychological evaluation with Subjective Units of Distress Scale (SUDS) at baseline, immediately after (Post-0), and after 10 minutes of resting (Post-10). These experimental procedures were performed to verify the acute effects of aerobic exercise on anxiety symptoms.</p><p>During the chronic experimental phase, patients performed 12 sessions of aerobic exercise (2<sup>nd</sup> to 13<sup>th</sup> day, see in the &#x0201c;Aerobic Exercise Protocol&#x0201d;). Aerobic exercise was performed with 48-72 hour rest interval between sessions. At the end of the chronic experimental phase (14<sup>th</sup> day), the same evaluations of the first visit (1<sup>st</sup> day) were performed, except for DSM-IV-TR (Post-intervention). Psychological evaluations were made by a senior psychologist. Electroencephalographic recording and VO<sub>2</sub>max assessment was made by an experienced professional of physical education. The aerobic exercise sessions were also accompanied by the same physical education professional. Patients in the control group were instructed to not exercise during the chronic experimental phase and remain on medication. The experimental procedures are shown in Fig. (<bold><xref ref-type="fig" rid="F1">1</xref></bold>).</p></sec><sec><label>2.3</label><title>Aerobic Exercise Protocol</title><p>All patients performed the training routine without interruptions and in the same calibrated treadmill (INBRAMED, Brazil). The patients performed 12 sessions with 48-72 hours of the interval between each one. They received information about the training procedures and also were encouraged to work until the end of the set time, but advised that they could also abort the training session to signal complications or fatigue. The intensity settings occurred at 45-50% of HRR for warm up, 50-55% of HRR for training and 45-50% of HRR for cool down. The warm up and cool down were performed with two minutes and thirty seconds, respectively, and aerobic training was performed on twenty minutes, totalizing 25 minutes. This prescription of aerobic exercise is in agreement with the American College of Sports Medicine [<xref rid="r30" ref-type="bibr">30</xref>].</p></sec><sec><label>2.4</label><title>Panic Disorder Severity Scale (PDSS)</title><p>The Panic Disorder Severity Scale (PDSS) is a questionnaire developed for measuring the severity of panic disorder [<xref rid="r31" ref-type="bibr">31</xref>].The PDSS consists of seven items that assess: 1) Panic frequency; 2) Distress during panic; 3) Panic-focused anticipatory anxiety; 4) Phobic avoidance of situations; 5) Phobic avoidance of physical sensations; 6) Impairment in work functioning; 7) Impairment in social functioning.</p><p>Each item is rated on a 5-point scale, which ranges from 0 to 4. The total scores range from 0 to 28.</p></sec><sec><label>2.5</label><title>Subjective Units of Distress Scale (SUDS)</title><p>Subjective Units of Distress Scale (SUDS) is a scale of 0 to 10 for measuring the subjective intensity of disturbance or distress currently experienced by an individual. The anxiety level has been measured with the Subjective Units of Distress Scale (SUDS) in patients with panic disorder [<xref rid="r32" ref-type="bibr">32</xref>-<xref rid="r34" ref-type="bibr">34</xref>].</p></sec><sec><label>2.6</label><title>Beck Anxiety Inventory (BAI)</title><p>Beck Anxiety Inventory (BAI) is a 21-question multiple-choice self-report inventory that is used for measuring the severity of anxiety [<xref rid="r35" ref-type="bibr">35</xref>]. Each answer is scored on a scale value of 0 (not at all) to 3 (severely). The BAI has been used as secondary outcomes of the anxiety in patients with panic disorder after aerobic exercise program [<xref rid="r10" ref-type="bibr">10</xref>, <xref rid="r28" ref-type="bibr">28</xref>].</p></sec><sec><label>2.7</label><title>Beck Depression Inventory-II (BDI-II)</title><p>Beck Depression Inventory-II (BDI-II) is a 21-question multiple-choice self-report inventory that is used for measuring the severity of depressive episodes [<xref rid="r36" ref-type="bibr">36</xref>]. Each answer is scored on a scale value of 0 (not at all) to 3 (severely).</p></sec><sec><label>2.8</label><title>Resting EEG Asymmetry</title><p>EEG signal was recorded by NeuroSpectrum-5 (Medical Instruments, S&#x000e3;o Paulo, Brazil). Nineteen monopolar electrodes were placed in the frontal areas (Fp1, Fp2, Fz, F3, F4, F7 and F8), central (Cz, C3 and C4), temporal (T3, T4, T5 and T6), parietal (Pz, and P3 P4) and occipital (O1 and O2) according to the International System 10/20 protocol [<xref rid="r37" ref-type="bibr">37</xref>]. Two other electrodes (<italic>i.e.</italic>, A1 and A2) were positioned in the earlobes with reference function (bi-auricular). The EEG suffers 0.05 Hz analog filtering (high pass) and 500 Hz (low-pass). EEG Sampling Rate is 5000 Hz and noise level is less than 0.3 &#x003bc;V. We used a digital notch filter 60 Hz and high-pass filters also on 0.5 Hz and low pass at 35 Hz.</p><p>The impedance levels of each electrode were observed, which should be between 5 and 10 KOhms (K&#x003a9;). EEG analyzes were performed in Neuron-Spectrum.NET-5 software. Initially, the artifacts were automatically removed, as spikes and sharp waves. In addition, the estimation of signal components by Independent Component Analysis (ICA) was applied to minimize artifacts. A visual inspection of the data to remove artifacts was performed, such as sweating and muscle tension.</p><p>Through Fast Fourier Transform (FFT), that refers to a signal analysis that repeats itself at regular time intervals, can set how much energy (power) is in each frequency band. The spectral absolute power was used with 1-s window for time of EEG, free of artifacts (spectral resolution of 0.25 Hz). The digital EEG systems of Neuron-Spectrum-5 series allow EEG recording in standard ranges delta, theta, alpha, beta and gamma. Epochs were extracted in the alpha frequency band (8-14Hz). The log transformation was applied (natural log ln) on the power values, since EEG power have not a normal distribution between subjects. This procedure results in a near normal distribution. EEG data were analyzed for cortical asymmetry according to Davidson hypothesis [<xref rid="r20" ref-type="bibr">20</xref>]. The basic mathematical calculation to compute the asymmetry was expressed by the equation: Resting EEG Asymmetry = InF4- InF3; the choice of Fronto-medial electrodes counterparts (F4-F3) was based on the prevalence of this measure in the literature related to exercise and association between asymmetry with reduction in anxiety scores [<xref rid="r22" ref-type="bibr">22</xref>, <xref rid="r23" ref-type="bibr">23</xref>].</p></sec><sec><label>2.9</label><title>Determination of the Maximal Oxygen Consumption (VO<sub>2</sub>Max)</title><p>For determination of VO<sub>2</sub>max, the submaximal protocol of Oliveira <italic>et al.</italic> was used [<xref rid="r38" ref-type="bibr">38</xref>]. Thus, patients remained seated for 10 min at rest, and in acclimatized environment (20&#x000b0; - 21&#x000b0;C). After 10 minutes of rest, the resting heart rate (HRrest) was measured by a specific monitor (model RS800, Polar&#x000ae;, Finland). The maximal Heart Rate (HRmax) was also determined by the following equation: 220 &#x02013; age (years).</p><p>The purpose of the test is to achieve the intensity corresponding to approximately 65% of Heart Rate Reserve (HRR). To determine the HRR, the equation was used: (HRmax - HRrest) x intensity + HRrest. Once hit, this intensity of effort is maintained for 6 minutes, characterizing a steady-state. It is expected that in the end of this stage FC was stabilized at approximately 70% of HRR. Intensity corresponds to the intensity that the patient should have reached during the test (65% of HRR) and maintain in steady state (70% of HRR) [<xref rid="r39" ref-type="bibr">39</xref>]. The submaximal protocol was performed with an initial warm up of 3 minutes on a treadmill (INBRAMED, Brazil), with a metabolic increment equivalent to 1 MET per minute, provided by the manipulation in the inclination of treadmill.</p><p>The VO<sub>2</sub> was obtained by the walking equation: VO<sub>2</sub> = [0,1 (speed) + 1.8 (speed) (inclination / 100) + 3.5], in which the speed is given in m/min. Finally, the VO<sub>2</sub>max was predicted by the equation: VO<sub>2</sub>max = [(VO<sub>2</sub> - 3.5) / %HRR + 3.5], in which VO<sub>2</sub>max is expressed in mL.kg<sup>-1</sup>.min<sup>-1</sup>(30).</p></sec><sec><label>2.10</label><title>Statistical Analysis</title><p>Descriptive statistics (mean and standard deviation) were calculated for age, body weight, height, SUDS, PDSS, BAI, BDI-II, VO<sub>2</sub>max, and resting EEG asymmetry. At baseline, independent samples t-tests were used to verify the differences between the two groups (Exercise group <italic>vs</italic> Control group). A 2 &#x000d7; 2 mixed factor analysis of variance was used to test for differences between control group and exercise group (between-group effects) and differences between baseline, immediately after (Post-0), and 10 minutes post-intervention (Post-10) (within-group effects) for SUDS. A 2 &#x000d7; 2 mixed factor analysis of variance was used to test for differences between control group and exercise group (between-group effects) and differences between baseline post-intervention (within-group effects) for PDSS, BAI, BDI-II, VO<sub>2</sub>max, and resting EEG asymmetry. Post-hoc analysis was performed using the Bonferroni to assess the effects within each group. Assumptions of the homogeneity of variance and residual normality were tested by using the Levene&#x02019;s and Shapiro-Wilk tests respectively. If assumptions were not met, changes in scores for those outcome measures were computed. Depending on the normality of the data, change scores for each group were compared by using independent samples t-test or Mann-Whitney U tests. Analyses were led separately for all the outcome variables including Panic SUDS, PDSS, BAI, BDI-II, VO<sub>2</sub>max, and resting EEG asymmetry. The level of significance was set at p &#x02264; 0.05.</p><p>Effect size analysis for each group was calculated by using Cohen&#x02019;s d. The following measures were used: PDSS, BAI, BDI-II, VO<sub>2</sub>max, and resting EEG asymmetry. Given that the calculation was for within group effects, we correlated both means and used Morris &#x00026;DeShon&#x02019;s [<xref rid="r40" ref-type="bibr">40</xref>] equation. Calculations were completed by using the G*POWER software (version 3.1). Effect sizes were classified as trivial (d &#x0003c;0.19), small (d = 0.20-0.49), moderate (d = 0.50-0.79), large (d = 0.80-1.29) and very large (&#x0003e; 1.30) [<xref rid="r41" ref-type="bibr">41</xref>].</p></sec></sec><sec sec-type="results"><label>3</label><title>RESULTS</title><p>At baseline, there were no significant group differences regarding age, height, SUDS, PDSS, BAI, BDI-II, VO<sub>2</sub>max, and resting EEG asymmetry (p &#x0003e; 0.05), with the exception of the body weight (p=0.03). Thereby, it can be assumed that participants in both groups were similar in relevant variables at the moment the intervention began (Table <bold><xref ref-type="table" rid="T1">1</xref></bold>).</p><sec><label>3.1</label><title>SUDS</title><p>Mixed analysis of variance showed significant group by time interaction (p = 0.026), and also significant main effects for time (p=0.001) for SUDS. Post-hoc analysis revealed a significant increase in SUDS in the exercise group after the intervention (Post-0= 3.8&#x000b1;0.8) compared to baseline (Baseline= 2.4&#x000b1;1.1; p=0.04) and after 10 minutes of resting (Post-10= 1.6&#x000b1;0.5; p = 0.003) (Fig. <bold><xref ref-type="fig" rid="F2">2</xref></bold>). There were no significant differences between the exercise and control groups at baseline (Exercise Group=2.4&#x000b1;1.1 <italic>vs</italic> Control Group= 2.2&#x000b1;0.8, p=0.76), immediately after (Exercise group=3.8&#x000b1;0.8 <italic>vs</italic> Control Group= 2.6&#x000b1;1.8, p=0.21) and after 10 minutes of resting (Exercise group=1.6&#x000b1;0.5 <italic>vs</italic> Control group= 2.2&#x000b1;1.0; p=0.30).</p></sec><sec><label>3.2</label><title>PDSS</title><p>The results showed no significant group by time interaction (p=0.41) and no significant main effects for time (p=0.18) for PDSS. Descriptive data are described in Table <bold><xref ref-type="table" rid="T2">2</xref></bold>.</p></sec><sec><label>3.3</label><title>BAI</title><p>Mixed analysis of variance showed significant group by time interaction (p=0.02), and main effects for time (p=0.02) for BAI. Post-hoc analysis revealed a significantly decreased score in BAI in the exercise group post-intervention (M&#x000b1;SD= 29.6&#x000b1;7.4) compared to baseline (M&#x000b1;SD= 24.0&#x000b1;7.1, p=0.005) (Fig. <bold><xref ref-type="fig" rid="F3">3</xref></bold>).</p><p>Independent samples t-test indicated significant between-group differences regarding BAI (Exercise Group=5.6&#x000b1;3.9 <italic>vs</italic> Control Group= 0.1&#x000b1;2.3, p = 0.02), showing that the exercise group had greater reductions in the scores (Fig. <bold><xref ref-type="fig" rid="F4">4</xref></bold>). Moreover, only the exercise group showed very large effect size (1.40) within group. Descriptive data can be observed in (Table <bold><xref ref-type="table" rid="T2">2</xref></bold>).</p></sec><sec><label>3.4</label><title>BDI-II</title><p>Mixed analysis of variance showed significant group by time interaction (p = 0.04), and no significant main effects for time (p = 0.09) for BDI-II. Post-hoc analysis revealed a significantly decreased score in BDI-II in the exercise group post-intervention (M&#x000b1;SD= 15.8&#x000b1;9.4) compared to baseline (M&#x000b1;SD= 21.6&#x000b1;10.7, p=0.01) Fig. (<bold><xref ref-type="fig" rid="F5">5</xref></bold>). Mann-Whitney&#x02019;s U test showed no between-group differences for BDI-II (Exercise group=5.8&#x000b1;5.3 <italic>vs</italic> Control group= -0.6&#x000b1;2.8, p= 0.09). However, only the exercise group showed large effect size (1.06) within group. Descriptive data are seen in Table <bold><xref ref-type="table" rid="T2">2</xref></bold>.</p></sec><sec><label>3.5</label><title>VO<sub>2</sub>max</title><p>Mixed analysis of variance showed significant group by time interaction (p &#x0003c; 0.001), and also significant main effects for time (p &#x0003c; 0.001) for VO<sub>2</sub>max. Post-hoc analysis revealed a significant increase in VO<sub>2</sub>max in the exercise group post-intervention (M&#x000b1;SD= 38.3&#x000b1;2.2 mL.kg<sup>-1</sup>.min<sup>-1</sup>) compared to baseline (M&#x000b1;SD= 35.4&#x000b1;2.7 mL.kg<sup>-1</sup>.min<sup>-1</sup>, p &#x0003c; 0.001). In addition, VO<sub>2</sub>max was greater in the exercise group compared to the control group in post-intervention (Exercise group= 38.3&#x000b1;2.2 mL.kg<sup>-1</sup>.min<sup>-1</sup><italic> vs </italic>Control group= 32.3&#x000b1;2.7 mL.kg<sup>-1</sup>.min<sup>-1</sup>, p=0.005) (Fig. <bold><xref ref-type="fig" rid="F6">6</xref></bold>).</p><p>Independent samples t-test indicated significant between-group differences regarding VO<sub>2</sub>max (Exercise group= 2.9&#x000b1;0.6 mL.kg<sup>-1</sup>.min<sup>-1</sup>
<italic>vs</italic> Control group= 0.04&#x000b1;0.5 mL.kg<sup>-1</sup>.min<sup>-1</sup>, p &#x0003c; 0.001) (Fig. <bold><xref ref-type="fig" rid="F7">7</xref></bold>). Besides, results of the effect size between (<italic>d</italic>= 2.43) and within groups (<italic>d</italic>= 4.15) showed very largely, in favor of exercise group. Descriptive data are shown in (Table <bold><xref ref-type="table" rid="T2">2</xref></bold>).</p></sec><sec><label>3.6</label><title>Resting EEG asymmetry</title><p>Results showed no significant group by time interaction (p=0.43) and no significant main effects for time (p=0.46) for resting EEG asymmetry (Fig. <bold><xref ref-type="fig" rid="F8">8</xref></bold>). Descriptive data can be seen in Table <bold><xref ref-type="table" rid="T2">2</xref></bold>.</p></sec></sec><sec sec-type="discussion"><label>4</label><title>DISCUSSION</title><p>The aim of study was to verify the acute effects of aerobic exercise on the symptoms of anxiety and to investigate the chronic effects of aerobic exercise on severity and symptoms related to PD, besides the changes caused on EEG frontal asymmetry. Acute effects of exercise provided increases in anxiety immediately after and significant reductions after 10 min of recovery. The regular practice of aerobic exercise generated greater reductions in symptoms related to PD, BAI and BDI-II. However, no changes were demonstrated in PDSS and frontal EEG asymmetry in both groups.</p><p>In fact aerobic exercise can promote increase in anxiety acutely and other researches corroborated our findings [<xref rid="r14" ref-type="bibr">14</xref>, <xref rid="r15" ref-type="bibr">15</xref>]. Rief and Hermanutz [<xref rid="r15" ref-type="bibr">15</xref>] submitted patients with PD to two experimental conditions, exercise and control. The exercise was performed in the cycle ergometer, with duration of two minutes and intensity of 75 watts. The results showed that patients with PD had elevated anxiety scores after physical activation, but also after rest. Strohle <italic>et al.</italic> [<xref rid="r14" ref-type="bibr">14</xref>] also investigated the effects of quiet rest or an aerobic treadmill exercise on antipanic and anxiolytic activity in patients with PD. Aerobic exercise was performed in treadmill, 30 min at an intensity of 70% of VO<sub>2</sub>max. Results showed that somatic anxiety subscore were higher after exercise compared to rest and no results have been demonstrated for anxiety symptoms subscore. It is expected that some somatic symptoms increase during exercise and that responses of increase in anxiety levels are linked to this factor, as corroborated by the study of Strohle <italic>et al.</italic> [<xref rid="r14" ref-type="bibr">14</xref>]. Our findings shows this increase in anxiety may be related to possible changes in somatic symptoms. However, although aerobic exercise has promoted increased levels of anxiety, exercise exposure may provide antipanic protective effect. Strohle <italic>et al.</italic> [<xref rid="r14" ref-type="bibr">14</xref>] showed that CCK-4-induced panic attacks were less frequent after prior exercise (Exercise= 4 patients, 33.3% and Rest= 9 patients, 75%). Compared to prior rest, exercise resulted in a significantly reduced CCK-4-induced increase of the total Acute Panic Inventory (API) score and the anxiety subscore. Esquivel <italic>et al.</italic> [<xref rid="r11" ref-type="bibr">11</xref>] also demonstrated the protective effect of exercise for panic attacks and levels of anxiety. Patients participated in two experimental conditions, moderate/hard exercise (to reach and sustain on the cycloergometer 80 and 90% of their maximal heart rate for 15 minutes with or until exhaustion) or a very-light exercise (15 minutes, 1watts per kg, and 20 at 70 rpm, control group). Panic reactions to CO<sub>2</sub> were smaller in patients that performed moderate/hard exercise in contrast to those that performed very-light exercise.</p><p>Due to therapeutic potential of acute aerobic exercise, this intervention non-pharmacological was investigated also chronically. Our results showed that aerobic exercise reduced anxiety after 12 training sessions and data of randomized controlled trials suggest higher sizes for the effect of exercise on anxiety [<xref rid="r42" ref-type="bibr">42</xref>]. Bandelow <italic>et al.</italic> [<xref rid="r18" ref-type="bibr">18</xref>] submitted the patients to three treatment conditions: clomipramine, placebo and aerobic exercise (walking or running). Both exercise and clomipramine led to a significant decrease of anxiety symptoms in according to the P&#x00026;A and HAM-A, in comparison to placebo treatment. Clomipramine was significantly more effective than aerobic exercise. Similar results were found in the Broocks <italic>et al.</italic> [<xref rid="r28" ref-type="bibr">28</xref>] and Meyer <italic>et al.</italic> [<xref rid="r17" ref-type="bibr">17</xref>]. Although the anxiolytic and antipanic effects of exercise have already been empirically observed, the mechanisms of action involved remain to be elucidated. Several plausible mediators have been set forward to explain the antipanic and anxiolytic effects of exercise. Current studies have centered on mechanisms related to the brain-derived neurotrophic factor [<xref rid="r43" ref-type="bibr">43</xref>], atrial natriuretic peptide [<xref rid="r12" ref-type="bibr">12</xref>], and the serotonergic system [<xref rid="r44" ref-type="bibr">44</xref>].</p><p>Wedekind <italic>et al.</italic> [<xref rid="r19" ref-type="bibr">19</xref>] showed no improvement in anxiety after regular aerobic exercise. In this study, patients were divided into four experimental groups: aerobic exercise with paroxetine, relaxation with paroxetine, aerobic exercise with placebo, or relaxation with placebo. Results showed that response and remission rates were higher in the groups using paroxetine, regardless of exercise or relaxation, compared to placebo groups. Aerobic exercise showed a trend of improvement compared to the relaxation group, seen only in the fourth week. It is still necessary to establish the duration, frequency and intensity of aerobic exercise that promotes the beneficial organic adaptations to patients with PD. In our research, the aerobic exercise protocol was established according to the ACSM recommendations [<xref rid="r30" ref-type="bibr">30</xref>] and the control over aerobic exercise intensity has been subjective in others studies [<xref rid="r17" ref-type="bibr">17</xref>-<xref rid="r19" ref-type="bibr">19</xref>]. The intensity settings at 50-55% of HRR for training and twenty minutes of duration is recommended for sedentary subjects and low cardiorespiratory fitness [<xref rid="r30" ref-type="bibr">30</xref>]. Patients with PD showed lower VO<sub>2</sub>max, as well as lower exercise tolerance [<xref rid="r45" ref-type="bibr">45</xref>]. With this, our training prescription seems appropriate.</p><p>In addition to reductions in anxiety levels, our research demonstrated that regular aerobic exercise provided an increase in VO<sub>2</sub>max and reductions in depression scores. These results suggest that regular aerobic exercise, in comparison with control group, is associated with significant clinical improvement in PD patients. Martinsen <italic>et al.</italic> [<xref rid="r46" ref-type="bibr">46</xref>] reported the results of a protocol of 60 min of AE at 70% of VO<sub>2</sub>max, 3 times a week for 8 weeks, in which they observed a significant increase in VO<sub>2</sub>max with significant reductions in depression scores.</p><p>Our hypothesis was not confirmed for the increase in resting EGG asymmetry related to regular practice of aerobic exercise compared to control group. No changes in resting EEG frontal asymmetry were observed. To date, no study investigated changes in resting EEG asymmetry caused by regular practice of aerobic exercise. Lattari <italic>et al.</italic> [<xref rid="r27" ref-type="bibr">27</xref>] showed that acute aerobic exercise does not change resting EEG asymmetry.</p><p>A limitation of our study is the impossibility to establish double-blind conditions. Besides, our results should be interpreted with caution due to sample size. PD patients generally are afraid to do exercise because of the physiological responses that are similar to panic symptoms. However, our research was innovative in the most appropriate control of aerobic training. In addition, it was the first study to investigate the effects of aerobic exercise on resting EEG asymmetry in patients with PD.</p></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>In conclusion, aerobic exercise can promote increase in anxiety acutely. However, regular aerobic exercise promotes reduction in anxiety levels. In addition, the regular practice of aerobic exercise promotes other interesting improvements such as maximal oxygen consumption and reduction in the symptoms of depression. The hypothesis of resting EEG asymmetry in the exercise group in post-intervention was not confirmed. Future researches should further examine how the frontal asymmetry is associated with changes in anxiety after the regular practice of aerobic exercise.</p></sec></body><back><ack><title>ACKNOWLEDGEMENTS</title><p>Eduardo Lattari acknowledges the financial support of the Coordena&#x000e7;&#x000e3;o de Aperfei&#x000e7;oamento de Pessoal de N&#x000ed;vel Superior (CAPES).</p></ack><glossary><title>LIST OF ABBREVIATIONS</title><def-list><def-item><term>PD</term><def><p>= Panic Disorder</p></def></def-item><def-item><term>PAs</term><def><p>= Panic Attacks</p></def></def-item><def-item><term>CBT</term><def><p>= Cognitive Behavioural Therapy</p></def></def-item><def-item><term>CO<sub>2</sub></term><def><p>= Carbon dioxide</p></def></def-item><def-item><term>CCK-4</term><def><p>= Cholecystokinin-tetrapeptide</p></def></def-item><def-item><term>P &#x00026;A</term><def><p>= Panic and Agoraphobia Scale</p></def></def-item><def-item><term>VO<sub>2</sub>max</term><def><p>= Maximal oxygen consumption</p></def></def-item><def-item><term>EEG</term><def><p>= Electroencephalographic</p></def></def-item><def-item><term>BAI</term><def><p>= Beck Anxiety Inventory</p></def></def-item><def-item><term>BDI-II</term><def><p>= Beck Depression Inventory-II</p></def></def-item><def-item><term>PDSS</term><def><p>= Panic Disorder Severity Scale</p></def></def-item><def-item><term>SUDS</term><def><p>= Subjective Units of Distress Scale</p></def></def-item><def-item><term>&#x003bc;V</term><def><p>= MicroVolts</p></def></def-item><def-item><term>Hz</term><def><p>= Hertz</p></def></def-item><def-item><term>K&#x003a9;</term><def><p>= KOhms</p></def></def-item><def-item><term>FFT</term><def><p>= Fast Fourier Transform</p></def></def-item><def-item><term>ACSM</term><def><p>= American College of Sports Medicine</p></def></def-item><def-item><term>API</term><def><p>= Acute Panic Inventory</p></def></def-item><def-item><term>rpm</term><def><p>= Rotations per minute</p></def></def-item><def-item><term>HAM-A</term><def><p>= Hamilton Anxiety Scale</p></def></def-item></def-list></glossary><sec><title>ETHICS APPROVAL AND CONSENT TO PARTICIPATE</title><p>The Ethical Committee from Institute of Psychiatry of Federal University of Rio de Janeiro approved the study protocol, which conforms to the Helsinki Declaration. All the participants were able to sign and provide a written informed consent.</p></sec><sec><title>HUMAN AND ANIMAL RIGHTS</title><p>No Animals were used in this research. All human research procedures followed were in accordance with the ethical standards of the committee responsible for human experimentation (institutional and national), and with the Helsinki Declaration of 1975, as revised in 2008.</p></sec><sec><title>CONSENT FOR PUBLICATION</title><p>Each patient was clarified of all the experimental procedures and signed a written consent form.</p></sec><sec><title>CONFLICT OF INTEREST</title><p> The authors declare no conflict of interest, financial or otherwise.</p></sec><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Association</surname><given-names>A.P.</given-names></name></person-group><source>Diagnostic and statistical manual of mental disorders: DSM-IV-TR.</source><year>2000</year><edition>4th ed</edition><publisher-loc>Washington</publisher-loc><publisher-name>APA</publisher-name></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Jonge</surname><given-names>P.</given-names></name><name><surname>Roest</surname><given-names>A.M.</given-names></name><name><surname>Lim</surname><given-names>C.C.</given-names></name><name><surname>Florescu</surname><given-names>S.E.</given-names></name><name><surname>Bromet</surname><given-names>E.J.</given-names></name><name><surname>Stein</surname><given-names>D.J.</given-names></name><name><surname>Harris</surname><given-names>M.</given-names></name><name><surname>Nakov</surname><given-names>V.</given-names></name><name><surname>Caldas-de-Almeida</surname><given-names>J.M.</given-names></name><name><surname>Levinson</surname><given-names>D.</given-names></name><name><surname>Al-Hamzawi</surname><given-names>A.O.</given-names></name><name><surname>Haro</surname><given-names>J.M.</given-names></name><name><surname>Viana</surname><given-names>M.C.</given-names></name><name><surname>Borges</surname><given-names>G.</given-names></name><name><surname>O&#x02019;Neill</surname><given-names>S.</given-names></name><name><surname>de Girolamo</surname><given-names>G.</given-names></name><name><surname>Demyttenaere</surname><given-names>K.</given-names></name><name><surname>Gureje</surname><given-names>O.</given-names></name><name><surname>Iwata</surname><given-names>N.</given-names></name><name><surname>Lee</surname><given-names>S.</given-names></name><name><surname>Hu</surname><given-names>C.</given-names></name><name><surname>Karam</surname><given-names>A.</given-names></name><name><surname>Moskalewicz</surname><given-names>J.</given-names></name><name><surname>Kovess-Masfety</surname><given-names>V.</given-names></name><name><surname>Navarro-Mateu</surname><given-names>F.</given-names></name><name><surname>Browne</surname><given-names>M.O.</given-names></name><name><surname>Piazza</surname><given-names>M.</given-names></name><name><surname>Posada-Villa</surname><given-names>J.</given-names></name><name><surname>Torres</surname><given-names>Y.</given-names></name><name><surname>Ten Have</surname><given-names>M.L.</given-names></name><name><surname>Kessler</surname><given-names>R.C.</given-names></name><name><surname>Scott</surname><given-names>K.M.</given-names></name></person-group><article-title>Cross-national epidemiology of panic disorder and panic attacks in the world mental health surveys.</article-title><source>Depress. Anxiety</source><year>2016</year><volume>33</volume><issue>12</issue><fpage>1155</fpage><lpage>1177</lpage><pub-id pub-id-type="doi">10.1002/da.22572</pub-id><pub-id pub-id-type="pmid">27775828</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soares-Filho</surname><given-names>G.L.</given-names></name><name><surname>Freire</surname><given-names>R.C.</given-names></name><name><surname>Biancha</surname><given-names>K.</given-names></name><name><surname>Pacheco</surname><given-names>T.</given-names></name><name><surname>Volschan</surname><given-names>A.</given-names></name><name><surname>Valen&#x000e7;a</surname><given-names>A.M.</given-names></name><name><surname>Nardi</surname><given-names>A.E.</given-names></name></person-group><article-title>Use of the Hospital Anxiety and Depression Scale (HADS) in a cardiac emergency room: Chest pain unit.</article-title><source>Clinics (Sao Paulo)</source><year>2009</year><volume>64</volume><issue>3</issue><fpage>209</fpage><lpage>214</lpage><pub-id pub-id-type="doi">10.1590/S1807-59322009000300011</pub-id><pub-id pub-id-type="pmid">19330247</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marciniak</surname><given-names>M.</given-names></name><name><surname>Lage</surname><given-names>M.J.</given-names></name><name><surname>Landbloom</surname><given-names>R.P.</given-names></name><name><surname>Dunayevich</surname><given-names>E.</given-names></name><name><surname>Bowman</surname><given-names>L.</given-names></name></person-group><article-title>Medical and productivity costs of anxiety disorders: Case control study.</article-title><source>Depress. Anxiety</source><year>2004</year><volume>19</volume><issue>2</issue><fpage>112</fpage><lpage>120</lpage><pub-id pub-id-type="doi">10.1002/da.10131</pub-id><pub-id pub-id-type="pmid">15022146</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Konnopka</surname><given-names>A.</given-names></name><name><surname>Leichsenring</surname><given-names>F.</given-names></name><name><surname>Leibing</surname><given-names>E.</given-names></name><name><surname>K&#x000f6;nig</surname><given-names>H.H.</given-names></name></person-group><article-title>Cost-of-illness studies and cost-effectiveness analyses in anxiety disorders: A systematic review.</article-title><source>J. Affect. Disord.</source><year>2009</year><volume>114</volume><issue>1-3</issue><fpage>14</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1016/j.jad.2008.07.014</pub-id><pub-id pub-id-type="pmid">18768222</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bandelow</surname><given-names>B</given-names></name><name><surname>Zohar</surname><given-names>J</given-names></name><name><surname>Hollander</surname><given-names>E</given-names></name><etal/></person-group><article-title>World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision. </article-title><source>The world journal of biological psychiatry: The Off. J. World Fed. Soc. Biol. Psychiatry. </source><year>2008</year><volume>9</volume><issue>4</issue><fpage>248</fpage><lpage>312</lpage></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chouinard</surname><given-names>G.</given-names></name></person-group><article-title>Issues in the clinical use of benzodiazepines: Potency, withdrawal, and rebound.</article-title><source>J. Clin. Psychiatry</source><year>2004</year><volume>65</volume><issue>Suppl. 5</issue><fpage>7</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">15078112</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bighelli</surname><given-names>I.</given-names></name><name><surname>Trespidi</surname><given-names>C.</given-names></name><name><surname>Castellazzi</surname><given-names>M.</given-names></name><name><surname>Cipriani</surname><given-names>A.</given-names></name><name><surname>Furukawa</surname><given-names>T.A.</given-names></name><name><surname>Girlanda</surname><given-names>F.</given-names></name><name><surname>Guaiana</surname><given-names>G.</given-names></name><name><surname>Koesters</surname><given-names>M.</given-names></name><name><surname>Barbui</surname><given-names>C.</given-names></name></person-group><article-title>Antidepressants and benzodiazepines for panic disorder in adults.</article-title><source>Cochrane Database Syst. Rev.</source><year>2016</year><volume>9</volume><fpage>CD011567</fpage><pub-id pub-id-type="pmid">27618521</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holt</surname><given-names>R.L.</given-names></name><name><surname>Lydiard</surname><given-names>R.B.</given-names></name></person-group><article-title>Management of treatment-resistant panic disorder.</article-title><source>Psychiatry (Edgmont.)</source><year>2007</year><volume>4</volume><issue>10</issue><fpage>48</fpage><lpage>59</lpage><pub-id pub-id-type="pmid">20428311</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaudlitz</surname><given-names>K.</given-names></name><name><surname>Plag</surname><given-names>J.</given-names></name><name><surname>Dimeo</surname><given-names>F.</given-names></name><name><surname>Str&#x000f6;hle</surname><given-names>A.</given-names></name></person-group><article-title>Aerobic exercise training facilitates the effectiveness of cognitive behavioral therapy in panic disorder.</article-title><source>Depress. Anxiety</source><year>2015</year><volume>32</volume><issue>3</issue><fpage>221</fpage><lpage>228</lpage><pub-id pub-id-type="doi">10.1002/da.22337</pub-id><pub-id pub-id-type="pmid">25515221</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esquivel</surname><given-names>G.</given-names></name><name><surname>D&#x000ed;az-Galvis</surname><given-names>J.</given-names></name><name><surname>Schruers</surname><given-names>K.</given-names></name><name><surname>Berlanga</surname><given-names>C.</given-names></name><name><surname>Lara-Mu&#x000f1;oz</surname><given-names>C.</given-names></name><name><surname>Griez</surname><given-names>E.</given-names></name></person-group><article-title>Acute exercise reduces the effects of a 35% CO2 challenge in patients with panic disorder.</article-title><source>J. Affect. Disord.</source><year>2008</year><volume>107</volume><issue>1-3</issue><fpage>217</fpage><lpage>220</lpage><pub-id pub-id-type="doi">10.1016/j.jad.2007.07.022</pub-id><pub-id pub-id-type="pmid">17727960</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Str&#x000f6;hle</surname><given-names>A.</given-names></name><name><surname>Feller</surname><given-names>C.</given-names></name><name><surname>Strasburger</surname><given-names>C.J.</given-names></name><name><surname>Heinz</surname><given-names>A.</given-names></name><name><surname>Dimeo</surname><given-names>F.</given-names></name></person-group><article-title>Anxiety modulation by the heart? Aerobic exercise and atrial natriuretic peptide.</article-title><source>Psychoneuroendocrinology</source><year>2006</year><volume>31</volume><issue>9</issue><fpage>1127</fpage><lpage>1130</lpage><pub-id pub-id-type="doi">10.1016/j.psyneuen.2006.08.003</pub-id><pub-id pub-id-type="pmid">17010527</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Youngstedt</surname><given-names>S.D.</given-names></name><name><surname>O&#x02019;Connor</surname><given-names>P.J.</given-names></name><name><surname>Crabbe</surname><given-names>J.B.</given-names></name><name><surname>Dishman</surname><given-names>R.K.</given-names></name></person-group><article-title>Acute exercise reduces caffeine-induced anxiogenesis.</article-title><source>Med. Sci. Sports Exerc.</source><year>1998</year><volume>30</volume><issue>5</issue><fpage>740</fpage><lpage>745</lpage><pub-id pub-id-type="doi">10.1097/00005768-199805000-00015</pub-id><pub-id pub-id-type="pmid">9588617</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Str&#x000f6;hle</surname><given-names>A.</given-names></name><name><surname>Graetz</surname><given-names>B.</given-names></name><name><surname>Scheel</surname><given-names>M.</given-names></name><name><surname>Wittmann</surname><given-names>A.</given-names></name><name><surname>Feller</surname><given-names>C.</given-names></name><name><surname>Heinz</surname><given-names>A.</given-names></name><name><surname>Dimeo</surname><given-names>F.</given-names></name></person-group><article-title>The acute antipanic and anxiolytic activity of aerobic exercise in patients with panic disorder and healthy control subjects.</article-title><source>J. Psychiatr. Res.</source><year>2009</year><volume>43</volume><issue>12</issue><fpage>1013</fpage><lpage>1017</lpage><pub-id pub-id-type="doi">10.1016/j.jpsychires.2009.02.004</pub-id><pub-id pub-id-type="pmid">19289240</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rief</surname><given-names>W.</given-names></name><name><surname>Hermanutz</surname><given-names>M.</given-names></name></person-group><article-title>Responses to activation and rest in patients with panic disorder and major depression.</article-title><source>Br. J. Clin. Psychol.</source><year>1996</year><volume>35</volume><issue>Pt 4</issue><fpage>605</fpage><lpage>616</lpage><pub-id pub-id-type="doi">10.1111/j.2044-8260.1996.tb01216.x</pub-id><pub-id pub-id-type="pmid">8955546</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinsen</surname><given-names>E.W.</given-names></name><name><surname>Raglin</surname><given-names>J.S.</given-names></name><name><surname>Hoffart</surname><given-names>A.</given-names></name><name><surname>Friis</surname><given-names>S.</given-names></name></person-group><article-title>Tolerance to intensive exercise and high levels of lactate in panic disorder.</article-title><source>J. Anxiety Disord.</source><year>1998</year><volume>12</volume><issue>4</issue><fpage>333</fpage><lpage>342</lpage><pub-id pub-id-type="doi">10.1016/S0887-6185(98)00018-8</pub-id><pub-id pub-id-type="pmid">9699117</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer</surname><given-names>T.</given-names></name><name><surname>Broocks</surname><given-names>A.</given-names></name><name><surname>Bandelow</surname><given-names>B.</given-names></name><name><surname>Hillmer-Vogel</surname><given-names>U.</given-names></name><name><surname>R&#x000fc;ther</surname><given-names>E.</given-names></name></person-group><article-title>Endurance training in panic patients: Spiroergometric and clinical effects.</article-title><source>Int. J. Sports Med.</source><year>1998</year><volume>19</volume><issue>7</issue><fpage>496</fpage><lpage>502</lpage><pub-id pub-id-type="doi">10.1055/s-2007-971951</pub-id><pub-id pub-id-type="pmid">9839848</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bandelow</surname><given-names>B.</given-names></name><name><surname>Broocks</surname><given-names>A.</given-names></name><name><surname>Pekrun</surname><given-names>G.</given-names></name><name><surname>George</surname><given-names>A.</given-names></name><name><surname>Meyer</surname><given-names>T.</given-names></name><name><surname>Pralle</surname><given-names>L.</given-names></name><name><surname>Bartmann</surname><given-names>U.</given-names></name><name><surname>Hillmer-Vogel</surname><given-names>U.</given-names></name><name><surname>R&#x000fc;ther</surname><given-names>E.</given-names></name></person-group><article-title>The use of the Panic and Agoraphobia Scale (P &#x00026; A) in a controlled clinical trial.</article-title><source>Pharmacopsychiatry</source><year>2000</year><volume>33</volume><issue>5</issue><fpage>174</fpage><lpage>181</lpage><pub-id pub-id-type="doi">10.1055/s-2000-12982</pub-id><pub-id pub-id-type="pmid">11071019</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wedekind</surname><given-names>D</given-names></name><name><surname>Broocks</surname><given-names>A</given-names></name><name><surname>Weiss</surname><given-names>N</given-names></name><etal/></person-group><article-title>A randomized, controlled trial of aerobic exercise in combination with paroxetine in the treatment of panic disorder.</article-title><source>The World J. Bio. Psych.: The Off. J. World Fed. Societ. Bio. Psych.</source><year>2010</year><volume>11</volume><issue>7</issue><fpage>904</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.3109/15622975.2010.489620</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davidson</surname><given-names>R.J.</given-names></name><name><surname>Ekman</surname><given-names>P.</given-names></name><name><surname>Saron</surname><given-names>C.D.</given-names></name><name><surname>Senulis</surname><given-names>J.A.</given-names></name><name><surname>Friesen</surname><given-names>W.V.</given-names></name></person-group><article-title>Approach-withdrawal and cerebral asymmetry: Emotional expression and brain physiology. I.</article-title><source>J. Pers. Soc. Psychol.</source><year>1990</year><volume>58</volume><issue>2</issue><fpage>330</fpage><lpage>341</lpage><pub-id pub-id-type="doi">10.1037/0022-3514.58.2.330</pub-id><pub-id pub-id-type="pmid">2319445</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jesulola</surname><given-names>E.</given-names></name><name><surname>Sharpley</surname><given-names>C.F.</given-names></name><name><surname>Bitsika</surname><given-names>V.</given-names></name><name><surname>Agnew</surname><given-names>L.L.</given-names></name><name><surname>Wilson</surname><given-names>P.</given-names></name></person-group><article-title>Frontal alpha asymmetry as a pathway to behavioural withdrawal in depression: Research findings and issues.</article-title><source>Behav. Brain Res.</source><year>2015</year><volume>292</volume><fpage>56</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1016/j.bbr.2015.05.058</pub-id><pub-id pub-id-type="pmid">26051816</pub-id></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moscovitch</surname><given-names>D.A.</given-names></name><name><surname>Santesso</surname><given-names>D.L.</given-names></name><name><surname>Miskovic</surname><given-names>V.</given-names></name><name><surname>McCabe</surname><given-names>R.E.</given-names></name><name><surname>Antony</surname><given-names>M.M.</given-names></name><name><surname>Schmidt</surname><given-names>L.A.</given-names></name></person-group><article-title>Frontal EEG asymmetry and symptom response to cognitive behavioral therapy in patients with social anxiety disorder.</article-title><source>Biol. Psychol.</source><year>2011</year><volume>87</volume><issue>3</issue><fpage>379</fpage><lpage>385</lpage><pub-id pub-id-type="doi">10.1016/j.biopsycho.2011.04.009</pub-id><pub-id pub-id-type="pmid">21571033</pub-id></element-citation></ref><ref id="r23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beaton</surname><given-names>E.A.</given-names></name><name><surname>Schmidt</surname><given-names>L.A.</given-names></name><name><surname>Ashbaugh</surname><given-names>A.R.</given-names></name><name><surname>Santesso</surname><given-names>D.L.</given-names></name><name><surname>Antony</surname><given-names>M.M.</given-names></name><name><surname>McCabe</surname><given-names>R.E.</given-names></name></person-group><article-title>Resting and reactive frontal brain electrical activity (EEG) among a non-clinical sample of socially anxious adults: Does concurrent depressive mood matter?</article-title><source>Neuropsychiatr. Dis. Treat.</source><year>2008</year><volume>4</volume><issue>1</issue><fpage>187</fpage><lpage>192</lpage><pub-id pub-id-type="pmid">18728822</pub-id></element-citation></ref><ref id="r24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coan</surname><given-names>J.A.</given-names></name><name><surname>Allen</surname><given-names>J.J.</given-names></name></person-group><article-title>Frontal EEG asymmetry as a moderator and mediator of emotion.</article-title><source>Biol. Psychol.</source><year>2004</year><volume>67</volume><issue>1-2</issue><fpage>7</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1016/j.biopsycho.2004.03.002</pub-id><pub-id pub-id-type="pmid">15130524</pub-id></element-citation></ref><ref id="r25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petruzzello</surname><given-names>S.J.</given-names></name><name><surname>Tate</surname><given-names>A.K.</given-names></name></person-group><article-title>Brain activation, affect, and aerobic exercise: An examination of both state-independent and state-dependent relationships.</article-title><source>Psychophysiology</source><year>1997</year><volume>34</volume><issue>5</issue><fpage>527</fpage><lpage>533</lpage><pub-id pub-id-type="doi">10.1111/j.1469-8986.1997.tb01739.x</pub-id><pub-id pub-id-type="pmid">9299907</pub-id></element-citation></ref><ref id="r26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woo</surname><given-names>M.</given-names></name><name><surname>Kim</surname><given-names>S.</given-names></name><name><surname>Kim</surname><given-names>J.</given-names></name><name><surname>Petruzzello</surname><given-names>S.J.</given-names></name><name><surname>Hatfield</surname><given-names>B.D.</given-names></name></person-group><article-title>The influence of exercise intensity on frontal electroencephalographic asymmetry and self-reported affect.</article-title><source>Res. Q. Exerc. Sport</source><year>2010</year><volume>81</volume><issue>3</issue><fpage>349</fpage><lpage>359</lpage><pub-id pub-id-type="doi">10.1080/02701367.2010.10599683</pub-id><pub-id pub-id-type="pmid">20949855</pub-id></element-citation></ref><ref id="r27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lattari</surname><given-names>E.</given-names></name><name><surname>Portugal</surname><given-names>E.</given-names></name><name><surname>Junior</surname><given-names>R.S.</given-names></name><name><surname>Oliveira</surname><given-names>B.R.</given-names></name><name><surname>Santos</surname><given-names>T.M.</given-names></name><name><surname>Mura</surname><given-names>G.</given-names></name><name><surname>Sancassiani</surname><given-names>F.</given-names></name><name><surname>Murillo-Rodriguez</surname><given-names>E.</given-names></name><name><surname>Arias-Carri&#x000f3;n</surname><given-names>O.</given-names></name><name><surname>Budde</surname><given-names>H.</given-names></name><name><surname>Rocha</surname><given-names>N.B.</given-names></name><name><surname>Machado</surname><given-names>S.</given-names></name></person-group><article-title>Acute affective responses and frontal electroencephalographic asymmetry to prescribed and self-selected exercise.</article-title><source>Clin. Pract. Epidemol Ment. Health</source><year>2016</year><volume>12</volume><fpage>108</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.2174/1745017901612010108</pub-id><pub-id pub-id-type="pmid">27867416</pub-id></element-citation></ref><ref id="r28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Broocks</surname><given-names>A.</given-names></name><name><surname>Bandelow</surname><given-names>B.</given-names></name><name><surname>Pekrun</surname><given-names>G.</given-names></name><name><surname>George</surname><given-names>A.</given-names></name><name><surname>Meyer</surname><given-names>T.</given-names></name><name><surname>Bartmann</surname><given-names>U.</given-names></name><name><surname>Hillmer-Vogel</surname><given-names>U.</given-names></name><name><surname>R&#x000fc;ther</surname><given-names>E.</given-names></name></person-group><article-title>Comparison of aerobic exercise, clomipramine, and placebo in the treatment of panic disorder.</article-title><source>Am. J. Psychiatry</source><year>1998</year><volume>155</volume><issue>5</issue><fpage>603</fpage><lpage>609</lpage><pub-id pub-id-type="doi">10.1176/ajp.155.5.603</pub-id><pub-id pub-id-type="pmid">9585709</pub-id></element-citation></ref><ref id="r29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Str&#x000f6;hle</surname><given-names>A.</given-names></name></person-group><article-title>Physical activity, exercise, depression and anxiety disorders.</article-title><source>J. Neural Transm. (Vienna)</source><year>2009</year><volume>116</volume><issue>6</issue><fpage>777</fpage><lpage>784</lpage><pub-id pub-id-type="doi">10.1007/s00702-008-0092-x</pub-id><pub-id pub-id-type="pmid">18726137</pub-id></element-citation></ref><ref id="r30"><label>30</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>Medicine ACoS</collab></person-group><source>ACSM&#x02019;s guidelines for exercise testing and prescription.</source><year>2013</year><publisher-name>Lippincott Williams &#x00026; Wilkins</publisher-name></element-citation></ref><ref id="r31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shear</surname><given-names>M.K.</given-names></name><name><surname>Brown</surname><given-names>T.A.</given-names></name><name><surname>Barlow</surname><given-names>D.H.</given-names></name><name><surname>Money</surname><given-names>R.</given-names></name><name><surname>Sholomskas</surname><given-names>D.E.</given-names></name><name><surname>Woods</surname><given-names>S.W.</given-names></name><name><surname>Gorman</surname><given-names>J.M.</given-names></name><name><surname>Papp</surname><given-names>L.A.</given-names></name></person-group><article-title>Multicenter collaborative panic disorder severity scale.</article-title><source>Am. J. Psychiatry</source><year>1997</year><volume>154</volume><issue>11</issue><fpage>1571</fpage><lpage>1575</lpage><pub-id pub-id-type="doi">10.1176/ajp.154.11.1571</pub-id><pub-id pub-id-type="pmid">9356566</pub-id></element-citation></ref><ref id="r32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freire</surname><given-names>R.C.</given-names></name><name><surname>De Carvalho</surname><given-names>M.R.</given-names></name><name><surname>Joffily</surname><given-names>M.</given-names></name><name><surname>Zin</surname><given-names>W.A.</given-names></name><name><surname>Nardi</surname><given-names>A.E.</given-names></name></person-group><article-title>Anxiogenic properties of a computer simulation for panic disorder with agoraphobia.</article-title><source>J. Affect. Disord.</source><year>2010</year><volume>125</volume><issue>1-3</issue><fpage>301</fpage><lpage>306</lpage><pub-id pub-id-type="doi">10.1016/j.jad.2009.12.031</pub-id><pub-id pub-id-type="pmid">20100626</pub-id></element-citation></ref><ref id="r33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>N.B.</given-names></name><name><surname>Zvolensky</surname><given-names>M.J.</given-names></name></person-group><article-title>Anxiety sensitivity and CO<sub>2</sub> challenge reactivity as unique and interactive prospective predictors of anxiety pathology.</article-title><source>Depress. Anxiety</source><year>2007</year><volume>24</volume><issue>8</issue><fpage>527</fpage><lpage>536</lpage><pub-id pub-id-type="doi">10.1002/da.20267</pub-id><pub-id pub-id-type="pmid">17136755</pub-id></element-citation></ref><ref id="r34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Peski-Oosterbaan</surname><given-names>A.S.</given-names></name><name><surname>Spinhoven</surname><given-names>P.</given-names></name><name><surname>Van der Does</surname><given-names>A.J.</given-names></name><name><surname>Willems</surname><given-names>L.N.</given-names></name><name><surname>Sterk</surname><given-names>P.J.</given-names></name></person-group><article-title>Is there a specific relationship between asthma and panic disorder?</article-title><source>Behav. Res. Ther.</source><year>1996</year><volume>34</volume><issue>4</issue><fpage>333</fpage><lpage>340</lpage><pub-id pub-id-type="doi">10.1016/0005-7967(95)00080-1</pub-id><pub-id pub-id-type="pmid">8871365</pub-id></element-citation></ref><ref id="r35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beck</surname><given-names>A.T.</given-names></name><name><surname>Epstein</surname><given-names>N.</given-names></name><name><surname>Brown</surname><given-names>G.</given-names></name><name><surname>Steer</surname><given-names>R.A.</given-names></name></person-group><article-title>An inventory for measuring clinical anxiety: Psychometric properties.</article-title><source>J. Consult. Clin. Psychol.</source><year>1988</year><volume>56</volume><issue>6</issue><fpage>893</fpage><lpage>897</lpage><pub-id pub-id-type="doi">10.1037/0022-006X.56.6.893</pub-id><pub-id pub-id-type="pmid">3204199</pub-id></element-citation></ref><ref id="r36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beck</surname><given-names>A.T.</given-names></name><name><surname>Steer</surname><given-names>R.A.</given-names></name><name><surname>Ball</surname><given-names>R.</given-names></name><name><surname>Ranieri</surname><given-names>W.</given-names></name></person-group><article-title>Comparison of beck depression inventories -IA and -II in psychiatric outpatients.</article-title><source>J. Pers. Assess.</source><year>1996</year><volume>67</volume><issue>3</issue><fpage>588</fpage><lpage>597</lpage><pub-id pub-id-type="doi">10.1207/s15327752jpa6703_13</pub-id><pub-id pub-id-type="pmid">8991972</pub-id></element-citation></ref><ref id="r37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jasper</surname><given-names>H.</given-names></name></person-group><article-title>Report of committee on methods of clinical examination in eletroencephalography.</article-title><source>Electroencephalogr. Clin. Neurophysiol.</source><year>1958</year><volume>10</volume><fpage>370</fpage><lpage>375</lpage><pub-id pub-id-type="doi">10.1016/0013-4694(58)90053-1</pub-id></element-citation></ref><ref id="r38"><label>38</label><element-citation publication-type="journal"><collab>Oliveira N.</collab><source>Avalia&#x000e7;&#x000e3;o da aptid&#x000e3;o cardiorrespirat&#x000f3;ria por meio de protocolo subm&#x000e1;ximo em idosos com transtorno de humor e doen&#x000e7;a de Parkinson. Arch clin psychiatry (S&#x000e3;o Paulo, Impr).</source><year>2013</year><volume>40</volume><issue>3</issue><fpage>88</fpage><lpage>92</lpage></element-citation></ref><ref id="r39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swain</surname><given-names>D.P.</given-names></name><name><surname>Leutholtz</surname><given-names>B.C.</given-names></name><name><surname>King</surname><given-names>M.E.</given-names></name><name><surname>Haas</surname><given-names>L.A.</given-names></name><name><surname>Branch</surname><given-names>J.D.</given-names></name></person-group><article-title>Relationship between % heart rate reserve and % VO<sub>2</sub> reserve in treadmill exercise.</article-title><source>Med. Sci. Sports Exerc.</source><year>1998</year><volume>30</volume><issue>2</issue><fpage>318</fpage><lpage>321</lpage><pub-id pub-id-type="doi">10.1097/00005768-199802000-00022</pub-id><pub-id pub-id-type="pmid">9502363</pub-id></element-citation></ref><ref id="r40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname><given-names>S.B.</given-names></name><name><surname>DeShon</surname><given-names>R.P.</given-names></name></person-group><article-title>Combining effect size estimates in meta-analysis with repeated measures and independent-groups designs.</article-title><source>Psychol. Methods</source><year>2002</year><volume>7</volume><issue>1</issue><fpage>105</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.1037/1082-989X.7.1.105</pub-id><pub-id pub-id-type="pmid">11928886</pub-id></element-citation></ref><ref id="r41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenthal</surname><given-names>J.A.</given-names></name></person-group><article-title>Qualitative descriptors of strength of association and effect size.</article-title><source>J. Soc. Serv. Res.</source><year>1996</year><volume>21</volume><issue>4</issue><fpage>37</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1300/J079v21n04_02</pub-id></element-citation></ref><ref id="r42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wegner</surname><given-names>M.</given-names></name><name><surname>Helmich</surname><given-names>I.</given-names></name><name><surname>Machado</surname><given-names>S.</given-names></name><name><surname>Nardi</surname><given-names>A.E.</given-names></name><name><surname>Arias-Carrion</surname><given-names>O.</given-names></name><name><surname>Budde</surname><given-names>H.</given-names></name></person-group><article-title>Effects of exercise on anxiety and depression disorders: Review of meta- analyses and neurobiological mechanisms.</article-title><source>CNS Neurol. Disord. Drug Targets</source><year>2014</year><volume>13</volume><issue>6</issue><fpage>1002</fpage><lpage>1014</lpage><pub-id pub-id-type="doi">10.2174/1871527313666140612102841</pub-id><pub-id pub-id-type="pmid">24923346</pub-id></element-citation></ref><ref id="r43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Str&#x000f6;hle</surname><given-names>A.</given-names></name><name><surname>Stoy</surname><given-names>M.</given-names></name><name><surname>Graetz</surname><given-names>B.</given-names></name><name><surname>Scheel</surname><given-names>M.</given-names></name><name><surname>Wittmann</surname><given-names>A.</given-names></name><name><surname>Gallinat</surname><given-names>J.</given-names></name><name><surname>Lang</surname><given-names>U.E.</given-names></name><name><surname>Dimeo</surname><given-names>F.</given-names></name><name><surname>Hellweg</surname><given-names>R.</given-names></name></person-group><article-title>Acute exercise ameliorates reduced brain-derived neurotrophic factor in patients with panic disorder.</article-title><source>Psychoneuroendocrinology</source><year>2010</year><volume>35</volume><issue>3</issue><fpage>364</fpage><lpage>368</lpage><pub-id pub-id-type="doi">10.1016/j.psyneuen.2009.07.013</pub-id><pub-id pub-id-type="pmid">19682803</pub-id></element-citation></ref><ref id="r44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greenwood</surname><given-names>B.N.</given-names></name><name><surname>Foley</surname><given-names>T.E.</given-names></name><name><surname>Day</surname><given-names>H.E.</given-names></name><name><surname>Burhans</surname><given-names>D.</given-names></name><name><surname>Brooks</surname><given-names>L.</given-names></name><name><surname>Campeau</surname><given-names>S.</given-names></name><name><surname>Fleshner</surname><given-names>M.</given-names></name></person-group><article-title>Wheel running alters serotonin (5-HT) transporter, 5-HT1A, 5-HT1B, and alpha 1b-adrenergic receptor mRNA in the rat raphe nuclei.</article-title><source>Biol. Psychiatry</source><year>2005</year><volume>57</volume><issue>5</issue><fpage>559</fpage><lpage>568</lpage><pub-id pub-id-type="doi">10.1016/j.biopsych.2004.11.025</pub-id><pub-id pub-id-type="pmid">15737672</pub-id></element-citation></ref><ref id="r45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>N.B.</given-names></name><name><surname>Lerew</surname><given-names>D.R.</given-names></name><name><surname>Santiago</surname><given-names>H.</given-names></name><name><surname>Trakowski</surname><given-names>J.H.</given-names></name><name><surname>Staab</surname><given-names>J.P.</given-names></name></person-group><article-title>Effects of heart-rate feedback on estimated cardiovascular fitness in patients with panic disorder.</article-title><source>Depress. Anxiety</source><year>2000</year><volume>12</volume><issue>2</issue><fpage>59</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1002/1520-6394(2000)12:2&#x0003c;59::AID-DA1&#x0003e;3.0.CO;2-G</pub-id><pub-id pub-id-type="pmid">11091928</pub-id></element-citation></ref><ref id="r46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinsen</surname><given-names>E.W.</given-names></name><name><surname>Hoffart</surname><given-names>A.</given-names></name><name><surname>Solberg</surname><given-names>O.</given-names></name></person-group><article-title>Comparing aerobic with nonaerobic forms of exercise in the treatment of clinical depression: A randomized trial.</article-title><source>Compr. Psychiatry</source><year>1989</year><volume>30</volume><issue>4</issue><fpage>324</fpage><lpage>331</lpage><pub-id pub-id-type="doi">10.1016/0010-440X(89)90057-6</pub-id><pub-id pub-id-type="pmid">2667882</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Fig. (1)</label><p>
Schematic representation of the experimental procedures.
</p><graphic xlink:href="CPEMH-14-11_F1"/></fig><fig id="F2" position="float"><label>Fig. (2)</label><p>
Acute effects of exercise on SUDS.
</p><graphic xlink:href="CPEMH-14-11_F2"/></fig><fig id="F3" position="float"><label>Fig. (3)</label><p>
Between and within-group comparisons for BAI.
</p><graphic xlink:href="CPEMH-14-11_F3"/></fig><fig id="F4" position="float"><label>Fig. (4)</label><p>
Independent samples t-test for changes in BAI scores.
</p><graphic xlink:href="CPEMH-14-11_F4"/></fig><fig id="F5" position="float"><label>Fig. (5)</label><p>
Between and within-group comparisons for BDI-II.
</p><graphic xlink:href="CPEMH-14-11_F5"/></fig><fig id="F6" position="float"><label>Fig. (6)</label><p>
Between and within-group comparisons for VO<sub>2</sub>max.
</p><graphic xlink:href="CPEMH-14-11_F6"/></fig><fig id="F7" position="float"><label>Fig. (7)</label><p>
Independent samples t-test for changes in VO<sub>2</sub>max.
</p><graphic xlink:href="CPEMH-14-11_F7"/></fig><fig id="F8" position="float"><label>Fig. (8)</label><p>
Between and within-group comparisons for resting EEG asymmetry.
</p><graphic xlink:href="CPEMH-14-11_F8"/></fig><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Descriptive data at baseline.</p></caption><table frame="border" rules="all" width="100%"><thead><tr><th rowspan="2" align="center" colspan="1">Variables</th><th colspan="2" valign="middle" align="center" rowspan="1">Baseline</th><th valign="middle" align="center" rowspan="1" colspan="1">-</th></tr></thead><tbody><tr><td valign="middle" align="center" rowspan="1" colspan="1">Exercise Group (n=5)<break/>
(M&#x000b1;SD)</td><td valign="middle" align="center" rowspan="1" colspan="1">Control Group (n=5)<break/>
(M&#x000b1;SD)</td><td valign="middle" align="center" rowspan="1" colspan="1">P</td></tr><tr><td valign="middle" align="center" rowspan="1" colspan="1">Age</td><td valign="middle" align="center" rowspan="1" colspan="1">36.4&#x000b1;3.5</td><td valign="middle" align="center" rowspan="1" colspan="1">42&#x000b1;8.4</td><td valign="middle" align="center" rowspan="1" colspan="1">0.20</td></tr><tr><td valign="middle" align="center" rowspan="1" colspan="1">Body weight (kg)</td><td valign="middle" align="center" rowspan="1" colspan="1">81&#x000b1;13.6</td><td valign="middle" align="center" rowspan="1" colspan="1">64&#x000b1;4.2</td><td valign="middle" align="center" rowspan="1" colspan="1">0.03*</td></tr><tr><td valign="middle" align="center" rowspan="1" colspan="1">Height (cm)</td><td valign="middle" align="center" rowspan="1" colspan="1">168.6&#x000b1;7.1</td><td valign="middle" align="center" rowspan="1" colspan="1">167.6&#x000b1;5.5</td><td valign="middle" align="center" rowspan="1" colspan="1">0.81</td></tr><tr><td valign="middle" align="center" rowspan="1" colspan="1">SUDS</td><td valign="middle" align="center" rowspan="1" colspan="1">2.4&#x000b1;1.1</td><td valign="middle" align="center" rowspan="1" colspan="1">2.2&#x000b1;0.8</td><td valign="middle" align="center" rowspan="1" colspan="1">0.76</td></tr><tr><td valign="middle" align="center" rowspan="1" colspan="1">PDSS</td><td valign="middle" align="center" rowspan="1" colspan="1">13.8&#x000b1;2.4</td><td valign="middle" align="center" rowspan="1" colspan="1">13.2&#x000b1;3.4</td><td valign="middle" align="center" rowspan="1" colspan="1">0.76</td></tr><tr><td valign="middle" align="center" rowspan="1" colspan="1">BAI</td><td valign="middle" align="center" rowspan="1" colspan="1">29.6&#x000b1;7.4</td><td valign="middle" align="center" rowspan="1" colspan="1">24.2&#x000b1;9.1</td><td valign="middle" align="center" rowspan="1" colspan="1">0.33</td></tr><tr><td valign="middle" align="center" rowspan="1" colspan="1">BDI-II</td><td valign="middle" align="center" rowspan="1" colspan="1">21.6&#x000b1;10.7</td><td valign="middle" align="center" rowspan="1" colspan="1">21.2&#x000b1;11.3</td><td valign="middle" align="center" rowspan="1" colspan="1">0.95</td></tr><tr><td valign="middle" align="center" rowspan="1" colspan="1">VO2max </td><td valign="middle" align="center" rowspan="1" colspan="1">35.4&#x000b1;2.7</td><td valign="middle" align="center" rowspan="1" colspan="1">32.2&#x000b1;2.2</td><td valign="middle" align="center" rowspan="1" colspan="1">0.08</td></tr><tr><td valign="middle" align="center" rowspan="1" colspan="1">Resting<break/>
EEG asymmetry</td><td valign="middle" align="center" rowspan="1" colspan="1">-0.0295</td><td valign="middle" align="center" rowspan="1" colspan="1">-0.0130</td><td valign="middle" align="center" rowspan="1" colspan="1">0.75</td></tr></tbody></table><table-wrap-foot><p>
Legend - Kg = kilogram; cm = centimeter; SUDS = Subjective Units of Distress Scale; PDSS = Panic Disorder Severity Scale; BAI = Beck Anxiety Inventory; BDI = Beck Depression Inventory-II; VO2max = maximum consumption oxygen in mL.kg-1.min-1; *Difference between groups at baseline.</p></table-wrap-foot></table-wrap><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Between and within-group comparisons and effect size analysis for all outcome measures.</p></caption><table frame="border" rules="all" width="100%"><thead><tr><th rowspan="2" align="center" colspan="1">Variables</th><th colspan="2" valign="middle" align="center" rowspan="1">Exercise Group (EG)</th><th colspan="2" valign="middle" align="center" rowspan="1">Control Group (CG)</th><th colspan="3" valign="middle" align="center" rowspan="1">Effect Sizes</th></tr></thead><tbody><tr><td valign="middle" align="center" rowspan="1" colspan="1">Baseline<break/>
(M&#x000b1;SD)</td><td valign="middle" align="center" rowspan="1" colspan="1">Post-intervention<break/>
(M&#x000b1;SD)</td><td valign="middle" align="center" rowspan="1" colspan="1">Baseline</td><td valign="middle" align="center" rowspan="1" colspan="1">Post-intervention<break/>
(M&#x000b1;SD)</td><td valign="middle" align="center" rowspan="1" colspan="1">Between-group</td><td valign="middle" align="center" rowspan="1" colspan="1">Within EG</td><td valign="middle" align="center" rowspan="1" colspan="1">Within CG</td></tr><tr><td valign="middle" align="center" rowspan="1" colspan="1">PDSS</td><td valign="middle" align="center" rowspan="1" colspan="1">13.8&#x000b1;2.4</td><td valign="middle" align="center" rowspan="1" colspan="1">13.0&#x000b1;2.0</td><td valign="middle" align="center" rowspan="1" colspan="1">13.2&#x000b1;3.4</td><td valign="middle" align="center" rowspan="1" colspan="1">13.0&#x000b1;3.3</td><td valign="middle" align="center" rowspan="1" colspan="1">0</td><td valign="middle" align="center" rowspan="1" colspan="1">0.75</td><td valign="middle" align="center" rowspan="1" colspan="1">0.18</td></tr><tr><td valign="middle" align="center" rowspan="1" colspan="1">BAI</td><td valign="middle" align="center" rowspan="1" colspan="1">29.6&#x000b1;7.4</td><td valign="middle" align="center" rowspan="1" colspan="1">24.0&#x000b1;7.1</td><td valign="middle" align="center" rowspan="1" colspan="1">24.2&#x000b1;9.1</td><td valign="middle" align="center" rowspan="1" colspan="1">24.2&#x000b1;8.2</td><td valign="middle" align="center" rowspan="1" colspan="1">0.02</td><td valign="middle" align="center" rowspan="1" colspan="1">1.40</td><td valign="middle" align="center" rowspan="1" colspan="1">0</td></tr><tr><td valign="middle" align="center" rowspan="1" colspan="1">BDI-II</td><td valign="middle" align="center" rowspan="1" colspan="1">21.6&#x000b1;10.7</td><td valign="middle" align="center" rowspan="1" colspan="1">15.8&#x000b1;9.4</td><td valign="middle" align="center" rowspan="1" colspan="1">21.2&#x000b1;11.3</td><td valign="middle" align="center" rowspan="1" colspan="1">21.8&#x000b1;10.2</td><td valign="middle" align="center" rowspan="1" colspan="1">-0.61</td><td valign="middle" align="center" rowspan="1" colspan="1">1.06</td><td valign="middle" align="center" rowspan="1" colspan="1">0.21</td></tr><tr><td valign="middle" align="center" rowspan="1" colspan="1">VO2max</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x000b1;2.7</td><td valign="middle" align="center" rowspan="1" colspan="1">38.3&#x000b1;2.2</td><td valign="middle" align="center" rowspan="1" colspan="1">32.2&#x000b1;2.2</td><td valign="middle" align="center" rowspan="1" colspan="1">32.3&#x000b1;2.7</td><td valign="middle" align="center" rowspan="1" colspan="1">2.43</td><td valign="middle" align="center" rowspan="1" colspan="1">4.15</td><td valign="middle" align="center" rowspan="1" colspan="1">0.16</td></tr><tr><td valign="middle" align="center" rowspan="1" colspan="1">Resting EEG asymmetry</td><td valign="middle" align="center" rowspan="1" colspan="1">-0.0295&#x000b1;0.08</td><td valign="middle" align="center" rowspan="1" colspan="1">-0.0280&#x000b1;0.04</td><td valign="middle" align="center" rowspan="1" colspan="1">-0.0130&#x000b1;0.07</td><td valign="middle" align="center" rowspan="1" colspan="1">-0.0553&#x000b1;0.05</td><td valign="middle" align="center" rowspan="1" colspan="1">-0.60</td><td valign="middle" align="center" rowspan="1" colspan="1">0.02</td><td valign="middle" align="center" rowspan="1" colspan="1">0.51</td></tr></tbody></table><table-wrap-foot><p>
Legend - PDSS = Panic Disorder Severity Scale; BAI = Beck Anxiety Inventory; BDI = Beck Depression Inventory-II; VO<sub>2</sub>max = maximum consumption oxygen in mL.kg<sup>-1</sup>.min<sup>-1</sup>.</p></table-wrap-foot></table-wrap></floats-group></article>